Ocular Therapeutix, Inc. (FRA:0OT)

Ocular Therapeutix Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,062	1,297	445	202	470	1,274
Market Cap Growth	59.33%	191.61%	119.64%	-56.87%	-63.15%	652.98%
Enterprise Value	1,832	957	420	145	364	1,264
Last Close Price	9.57	7.97	4.17	2.57	5.80	16.10
PS Ratio	43.38	21.07	8.41	4.20	12.27	89.57
PB Ratio	9.37	4.26	5.39	6.12	6.07	20.48
P/TBV Ratio	9.37	4.26	5.39	6.12	6.07	20.48
EV/Sales Ratio	38.20	15.54	7.94	3.01	9.50	88.85
Debt / Equity Ratio	0.30	0.24	0.92	1.82	0.67	0.77
Asset Turnover	0.12	0.18	0.29	0.29	0.19	0.10
Inventory Turnover	65.67	49.86	31.01	35.98	44.46	28.56
Quick Ratio	7.62	10.27	6.36	3.94	7.04	9.01
Current Ratio	7.85	10.66	6.66	4.13	7.26	9.23
Return on Equity (ROE)	-81.83%	-95.21%	-127.64%	-115.16%	-7.99%	-429.55%
Return on Assets (ROA)	-36.61%	-30.53%	-25.66%	-27.76%	-20.90%	-23.06%
Return on Capital (ROIC)	-43.27%	-38.31%	-37.56%	-39.86%	-34.65%	-41.29%
Return on Capital Employed (ROCE)	-73.00%	-41.60%	-37.90%	-66.70%	-43.70%	-26.70%
Earnings Yield	-10.32%	-14.41%	-16.42%	-32.83%	-1.23%	-9.98%
FCF Yield	-8.24%	-10.13%	-15.53%	-29.26%	-12.50%	-3.49%
Buyback Yield / Dilution	-26.34%	-84.90%	-3.57%	-0.59%	-35.24%	-34.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.